N. Nagai

发表

Development of a new Japanese guideline on drug interaction for drug development and appropriate provision of information.

R. Sato, Akihiro Ishiguro, N. Nagai, 2019, Drug metabolism and pharmacokinetics.

Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients

H. Ogata, A. Yokoyama, K. Masuhara, 1996, Cancer Chemotherapy and Pharmacology.

Drug interactions between theophylline and H2-antagonists, roxatidine acetate hydrochloride and cimetidine: pharmacokinetic analysis in rats in vivo.

M. Furuhata, H. Ogata, N. Nagai, 1995, Biological & pharmaceutical bulletin.

Model‐based approach to sampling optimization in studies of antibacterial drugs for infants and young children

Akira Okada, M. Kakara, N. Nagai, 2021, Clinical and translational science.

Population Pharmacokinetics and Pharmacodynamics of Cisplatin in Patients with Cancer: Analysis with the NONMEM Program

T. Igarashi, H. Ogata, A. Yokoyama, 1998, Journal of clinical pharmacology.

Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity

Kazuhiro Hotta, H. Ogata, N. Nagai, 2004, Cancer Chemotherapy and Pharmacology.

Present State of New Chiral Drug Development and Review in Japan

S. Toyoshima, H. Okuda, R. Shimazawa, 2008 .

Uptake of Cisplatin and its Metabolites Into Rat and Rabbit Renal Cortical Slices

K. Hanada, H. Ogata, N. Nagai, 1998 .

Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo

H. Ogata, N. Nagai, 1997, Cancer Chemotherapy and Pharmacology.

Decomposition Kinetics of Cisplatin in Human Biological Fluids

H. Ogata, N. Nagai, M. Kinoshita, 1996, The Journal of pharmacy and pharmacology.

Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.

K. Hanada, H. Ogata, N. Nagai, 1995, Journal of chromatography. B, Biomedical applications.

Drug interaction studies on new drug applications: current situations and regulatory views in Japan.

Naomi Nagai, N. Nagai, 2010, Drug metabolism and pharmacokinetics.

Variability in absorption lag time of pyridoxal phosphate under fasting and pre‐ and post‐meal conditions

H. Ogata, H. Takahashi, N. Nagai, 1994, Biopharmaceutics & drug disposition.

Classification of drugs for evaluating drug interaction in drug development and clinical management.

K. Maeda, Kiyomi Ito, A. Hisaka, 2021, Drug metabolism and pharmacokinetics.

COVID-19 Pandemic Challenges and Lessons Learned by Pharmacy Educators Around the Globe

M. Kawaguchi‐Suzuki, J. Desborough, R. Akonoghrere, 2020, American Journal of Pharmaceutical Education.

Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population.

A. Ohnishi, H. Ogata, M. Ishii, 1996, Biopharmaceutics & drug disposition.

Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan

Yoshiaki Uyama, Hideki Hanaoka, S. Toyoshima, 2005, Clinical pharmacology and therapeutics.

Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory Perspective

M Sato, Y Ochiai, S Kijima, 2017, CPT: pharmacometrics & systems pharmacology.

Examination of Time-to-onset of Interstitial Lung Disease, Cerebral Hemorrhage, and Gastrointestinal Hemorrhage in Very Elderly Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulant Using Data from the Japanese Adverse Drug Event Report (JADER) Database

S. Toyoshima, N. Nagai, K. Tanizawa, 2018 .

Improved high-performance liquid chromatographic analysis of teniposide in human plasma.

K. Mihara, H. Ogata, N. Nagai, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Development of a new Japanese guideline on drug interaction for drug development and appropriate provision of information.

R. Sato, Akihiro Ishiguro, N. Nagai, 2019, Drug metabolism and pharmacokinetics.

Co-Development of Oncology Drugs and Companion Diagnostics: Analyses of Approval Lags and Drug Development Periods in Recently Approved Cases in Japan

S. Toyoshima, N. Nagai, Akari Tanaka, 2021, Therapeutic Innovation & Regulatory Science.

Analysis of drug adverse events in elderly patients based on the Japanese Adverse Drug Event Report Database

Akira Okada, N. Nagai, S. Sera, 2022, Journal of clinical pharmacy and therapeutics.

The renal clearance of unchanged cisplatin during furosemide and mannitol diuresis is dependent on glomerular filtration rate in rats.

H. Ogata, N. Nagai, 1996, Journal of pharmaceutical sciences.